Abstract

Staphylocoagulase (SC) is a protein secreted by the human pathogen, Staphylococcus aureus, that activates human prothrombin (ProT) by inducing a conformational change. SC-bound ProT efficiently clots fibrinogen, thus bypassing the physiological blood coagulation pathway. The crystal structure of a fully active SC fragment, SC-(1-325), bound to human prethrombin 2 showed that the SC-(1-325) N terminus inserts into the Ile(16) pocket of prethrombin 2, thereby inducing expression of a functional catalytic site in the cognate zymogen without peptide bond cleavage. As shown here, SC-(1-325) binds to bovine and human ProT with similar affinity but activates the bovine zymogen only very poorly. By contrast to the approximately 2-fold difference in chromogenic substrate kinetic constants between human thrombin and the SC-(1-325).human (pro)thrombin complexes, SC-(1-325).bovine ProT shows a 3,500-fold lower k(cat)/K(m) compared with free bovine thrombin, because of a 47-fold increase in K(m) and a 67-fold decrease in k(cat). The SC-(1-325).bovine ProT complex is approximately 5,800-fold less active compared with its human counterpart. Comparison of human and bovine fibrinogen as substrates of human and bovine thrombin and the SC-(1-325).(pro)thrombin complexes indicates that the species specificity of SC-(1-325) cofactor activity is determined primarily by differences in conformational activation of bound ProT. These results suggest that the catalytic site in the SC-(1-325).bovine ProT complex is incompletely formed. The current crystal structure of SC-(1-325).bovine thrombin reveals that SC would dock similarly to the bovine proenzyme, whereas the bovine (pro)thrombin-characteristic residues Arg(144) and Arg(145) would likely interfere with insertion of the SC N terminus, thus explaining the greatly reduced activation of bovine ProT.

Highlights

  • Nistic point of view, these bacterial activators can be grouped into proteolytic and nonproteolytic ones (2)

  • The results demonstrated that SC-(1–325) bound both bovine ProT and ␣-thrombin and that the SC-(1–325)1⁄7bovine ProT complex was ϳ60fold less active as compared with the SC-(1–325)1⁄7human ProT complex under the conditions of the assays, indicating that SC-(1–325) is a much more effective activator of the human zymogen

  • The results demonstrated that SC-(1–325) activates bovine ProT but that the activity of the complex toward H-D-Phe-Pip-ArgpNA compared with the SC-(1–325)1⁄7bovine thrombin complex is 740fold lower, whereas the SC-(1–325) complex with human ProT is ϳ2-fold more active than SC-(1–325)1⁄7human thrombin measured with the same substrate (20)

Read more

Summary

The abbreviations used are

Plasminogen; SC, staphylocoagulase; SC-(1–325), staphylocoagulase fragment, residues 1–325; D1, crystallographically defined domain 1 of SC, residues 1–142; D2, crystallographically defined domain 2 of SC, residues 150 –281; Fbg, fibrinogen; [OG]FPR-ProT, N␣-[(acetylthio)acetyl]-D- Phe-ProArg-chloromethyl ketone-inactivated ProT labeled with 5-(and 6)-iodoacetamido2Ј,7Ј-difluorofluorescein; pNA, p-nitroaniline; ProT, prothrombin; Pm, plasmin; SK, streptokinase; Pre 2, prethrombin 2, the product of cleavage of ProT at Arg271-Thr[272]. We present the crystal structure of SC-(1–325) bound to bovine ␣-thrombin, along with a more detailed description and comparison of the atomic interactions in the SC-(1–325)1⁄7human (pre)thrombin and SC-(1–325)1⁄7bovine thrombin complexes to define structural differences responsible for the species specificity of ProT activation by SC

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Methods
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call